HL7 Terminology (THO)
5.1.0 - Publication
HL7 Terminology (THO)
5.1.0 - Publication
This page is part of the HL7 Terminology (v5.1.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions 
| Official URL: http://terminology.hl7.org/ValueSet/v2-0252 | Version: 2.0.0 | |||
| Active as of 2019-12-01 | Responsible: HL7, Inc | Computable Name: Hl7VSCausalityObservations | ||
| Other Identifiers: id: urn:oid:2.16.840.1.113883.21.159 | ||||
Copyright/Legal: Copyright HL7. Licensed under creative commons public domain |
||||
Value Set of codes that record event observations regarding what may have caused a product related event.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v2-0252
This value set contains 11 concepts
Expansion based on causalityObservations v2.1.0 (CodeSystem)
| Code | System | Display | Definition |
| AW | http://terminology.hl7.org/CodeSystem/v2-0252 | Abatement of event after product withdrawn | Abatement of event after product withdrawn |
| BE | http://terminology.hl7.org/CodeSystem/v2-0252 | Event recurred after product reintroduced | Event recurred after product reintroduced |
| LI | http://terminology.hl7.org/CodeSystem/v2-0252 | Literature reports association of product with event | Literature reports association of product with event |
| IN | http://terminology.hl7.org/CodeSystem/v2-0252 | Event occurred after product introduced | Event occurred after product introduced |
| EX | http://terminology.hl7.org/CodeSystem/v2-0252 | Alternative explanations for the event available | Alternative explanations for the event available |
| PL | http://terminology.hl7.org/CodeSystem/v2-0252 | Effect observed when patient receives placebo | Effect observed when patient receives placebo |
| TC | http://terminology.hl7.org/CodeSystem/v2-0252 | Toxic levels of product documented in blood or body fluids | Toxic levels of product documented in blood or body fluids |
| DR | http://terminology.hl7.org/CodeSystem/v2-0252 | Dose response observed | Dose response observed |
| SE | http://terminology.hl7.org/CodeSystem/v2-0252 | Similar events in past for this patient | Similar events in past for this patient |
| OE | http://terminology.hl7.org/CodeSystem/v2-0252 | Occurrence of event was confirmed by objective evidence | Occurrence of event was confirmed by objective evidence |
| OT | http://terminology.hl7.org/CodeSystem/v2-0252 | Other | Other |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
History
| Date | Action | Author | Custodian | Comment |
| 2020-05-06 | revise | Ted Klein | Vocabulary WG | Migrated to the UTG maintenance environment and publishing tooling. |
IG © 2020+ HL7 International - Vocabulary Work Group. Package hl7.terminology#5.1.0 based on FHIR 4.0.1. Generated 2023-02-25
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change